A Open-Label, Randomized, 2-sequence, 2-period, Fasted Condition, Single-dose, Per Oral, Cross-over Study to Evaluate the Bioequivalence of Dong-a Bepotastine Besilate Tab (Bepotastine Besilate 10mg) and Twolion Tab (Bepotastine Besilate 10mg) in Healthy Volunteers
Latest Information Update: 12 Feb 2020
At a glance
- Drugs Bepotastine (Primary)
- Indications Allergic conjunctivitis; Allergic rhinitis; Perennial allergic rhinitis; Pruritus; Urticaria
- Focus Pharmacokinetics
- Sponsors Dong-A ST
Most Recent Events
- 06 Feb 2020 Status changed from recruiting to completed.
- 03 May 2019 New trial record
- 01 May 2019 Status changed from not yet recruiting to recruiting.